Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

Abstract

Summary Background Global development goals increasingly rely on country-specific estimates for benchmarking a nation’s progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD 2017 provides a comprehensive assessment of cause-specific mortality for 282 causes in 195 countries and territories from 1980 to 2017. Methods The causes of death database is composed of vital registration (VR), verbal autopsy (VA), registry, survey, police, and surveillance data. GBD 2017 added ten VA studies, 127 country-years of VR data, 502 cancer-registry country-years, and an additional surveillance country-year. Expansions of the GBD cause of death hierarchy resulted in 18 additional causes estimated for GBD 2017. Newly available data led to subnational estimates for five additional countries—Ethiopia, Iran, New Zealand, Norway, and Russia. Deaths assigned International Classification of Diseases (ICD) codes for non-specific, implausible, or intermediate causes of death were reassigned to underlying causes by redistribution algorithms that were incorporated into uncertainty estimation. We used statistical modelling tools developed for GBD, including the Cause of Death Ensemble model (CODEm), to generate cause fractions and cause-specific death rates for each location, year, age, and sex. Instead of using UN estimates as in previous versions, GBD 2017 independently estimated population size and fertility rate for all locations. Years of life lost (YLLs) were then calculated as the sum of each death multiplied by the standard life expectancy at each age. All rates reported here are age-standardised. Findings At the broadest grouping of causes of death (Level 1), non-communicable diseases (NCDs) comprised the greatest fraction of deaths, contributing to 73·4% (95% uncertainty interval [UI] 72·5–74·1) of total deaths in 2017, while communicable, maternal, neonatal, and nutritional (CMNN) causes accounted for 18·6% (17·9–19·6), and injuries 8·0% (7·7–8·2). Total numbers of deaths from NCD causes increased from 2007 to 2017 by 22·7% (21·5–23·9), representing an additional 7·61 million (7·20–8·01) deaths estimated in 2017 versus 2007. The death rate from NCDs decreased globally by 7·9% (7·0–8·8). The number of deaths for CMNN causes decreased by 22·2% (20·0–24·0) and the death rate by 31·8% (30·1–33·3). Total deaths from injuries increased by 2·3% (0·5–4·0) between 2007 and 2017, and the death rate from injuries decreased by 13·7% (12·2–15·1) to 57·9 deaths (55·9–59·2) per 100 000 in 2017. Deaths from substance use disorders also increased, rising from 284 000 deaths (268 000–289 000) globally in 2007 to 352 000 (334 000–363 000) in 2017. Between 2007 and 2017, total deaths from conflict and terrorism increased by 118·0% (88·8–148·6). A greater reduction in ...

Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic

“…Specific populations both face and present unique challenges. Globally, tobacco use, alcohol and other drugs case an estimated 11.8 million people each year in 2016 [4]. Globally, substance use disorders are estimated to have a prevalence of 100.4 million persons for alcohol, 22.1 million for cannabis and 26.8 million for opioids.…”

“…Globally, substance use disorders are estimated to have a prevalence of 100.4 million persons for alcohol, 22.1 million for cannabis and 26.8 million for opioids. 4.2% of all disability-adjusted life years (DALYs) were attributable to alcohol use whilst 1.3% of all DALYS were attributed to other drugs [5]. There are an estimated 15.6 million people who inject drugs internationally [6].…”

From the Roundabout of Molecular Events to Nanomaterial-Induced Chronic Inflammation Prediction

“…Today, chronic diseases such as asthma, lung cancer, heart disease, and brain damage with accelerated cognitive decline, are considered to be some of the most significant causes of death [1][2][3] . These diseases are known to be associated with air pollution and inhalation of particulate matter and nanoparticles 4 , which, according to the OECD and WHO, kill four million people globally every year 5,6 .…”

Evaluating Public Health Interventions: A Neglected Area in Health Technology Assessment

“…Non-communicable diseases are the biggest drivers of global mortality, contributing to over 70% of total deaths in 2017. The vast majority of premature deaths occur in low-and middleincome countries in part due to behavioral risk factors such as increasing rates of tobacco and alcohol consumption, unbalanced diets, and physical inactivity (1).…”